Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Blood
Patent
1989-04-05
1991-01-29
Stone, Jacqueline
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Blood
424682, 514 23, 514561, A61K 3514, A61K 3170, A61K 31195
Patent
active
049885154
ABSTRACT:
An improved amino acid enriched cardioplegic solution adapted for use in preventing and treating heart muscle damage due to regional ischemia. The solution includes a calcium ion concentration of between about 50-300 umol, a metabolizable substrate concentration of 400-1000 mg % and an osmolarity of between about 400-500 mOsmols.
REFERENCES:
patent: 4249923 (1981-02-01), Walda
patent: 4254081 (1981-03-01), Streczyn et al.
patent: 4314550 (1982-02-01), Apstein
patent: 4415556 (1983-11-01), Bretschneider
patent: 4416280 (1983-11-01), Carpenter et al.
patent: 4427009 (1984-01-01), Wells et al.
patent: 4433971 (1984-02-01), Lindsay et al.
Bretschneider, H. J., Hobner, G., Knoll, D., Lohr, B., Nordbeck II, and Spieckermann, P. G., Myocardial resistance and tolerance to ischemia: Physiological and biochemical basis, J. Cardiovasc Surg 16, 241-260, 1975.
Schulte, H. G., Preusse, C. J., Groschopp, C., Bircks, W., and Bretschneider solution, Textbook of Clinical cardioplegia, Eds Engelman & Levitsky, pp. 199-210, 1982.
Follette, D. M., Mulder, D. G., Maloney, J. V., Buckberg, G. D., Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia, J. Thor and Cardiovasc Surg 76(5), 604-619, 1978.
Lavallee, M., Cox, D., Patrick, T. A., Vatner, S. F., Salvage of myocardial function by coronary artery reperfusion 1, 2 and 3 hours after occlusion in conscious dogs, Circulation Research 53(2), 235-247, 1983.
Jennings, R. B., Reimber, K. A., Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood, Circ 68:I, 25-36, 1983.
Selinger, S. L., Berg, R., Leonard, J. J., Coleman, W. S., DeWood, M. A., Surgical intervention in acute myocardial infarcation, Tx Hrt Inst J 11, 1:44-51, 1984.
Follette, D. M., Fey, K., Buckberg, G. D., Helly, J. J., Steed, D. L., Foglia, R. P., Maloney, J. V., Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity, J. Thor and Cardiovasc Surg 82(2), 221-238, 1981.
Rosenkranz, E. R., Buckberg, G. D., Myocardial protection during surgical coronary reperfusion, J Am Coll Cardiol 1(5), 1235-1246, 1983.
Rosenkranz, E. R., Buckberg, G. D., Laks, H., Mulder, D. G., Warm induction of cardioplegia with glutamate-enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intraaortic balloon support, J of Thor and Cardiovasc Surgery, vol. 86, No. 4, pp. 507-518, Oct. 1983.
Rosenkrantz, E., Medical Research Abstract Reproduction Form from American Heart Association, Oct. 1983.
Kugelmeier, J. et al., Clinical Evaluation of Three Methods of Myocardial Protection, pp. 436-443.
Lazar, H. L., Buckberg, G. D., Manganaro, A. M., Becker, H., Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion, J. Thor Cardiovasc Surg 80, 350-359, 1980.
Buckberg, G. D., A Proposed "Solution" to the Cardioplegic Controversey, J. Thor Cardiovasc Surg, vol. 77, No. 6, pp. 803-815, Jun. 1979.
The Lancet, Feb. 22, 1986, G1551, pp. 397-401.
J. Thoracic and Cardiovascular Surgery, vol. 92, No. 3, Part 2 Supplement.
The Merck Index "Succinic Acid", No. 8743, p. 1271, 10th Ed. 1983.
Irisawa et al. cited in Biological Abstracts 77(10):8073, Ref. 73310, 1984.
Koomen et al., cited in Chem. Abstracts, vol. 99, No. 860424, 1983.
Stone Jacqueline
The Regents of the Univ. of Calif.
LandOfFree
Cardioplegic solution does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardioplegic solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardioplegic solution will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-812357